Answer
It remains licensed, but longer-acting antibodies have replaced it in the high-risk infant programme. It may still be used if preferred alternatives are unavailable.
Sources for this answer
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.